Recurrent ETNK1 mutations in atypical chronic myeloid leukemia. por Gambacorti-Passerini, C, Donadoni, C, Parmiani, A, Pirola, A, Redaelli, S, Signore, G, Piazza, V, Malcovati, L, Fontana, D, Spinelli, R, Magistroni, V, Gaipa, G, Peronaci, M, Morotti, A, Panuzzo, C, Saglio, G, Usala, E, Kim, D, Rea, D, Zervakis, K, Viniou, N, Symeonidis, A, Becker, H, Boultwood, J, Campiotti, L

De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways por Magistroni, V, Mauri, M, D'Aliberti, D, Mezzatesta, C, Crespiatico, I, Nava, M, Fontana, D, Sharma, N, Parker, W, Schreiber, A, Yeung, D, Pirola, A, Redaelli, S, Massimino, L, Wang, P, Khandelwal, P, Citterio, S, Viltadi, M, Bombelli, S, Rigolio, R, Perego, R, Boultwood, J, Morotti, A, Saglio, G, Kim, D, Branford, S, Gambacorti-Passerini, C, Piazza, R